Bibliografia UJ CM

1/2
Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck-Popovic, Pavel Bician, Miklós Garami, Toby Trahair, Adela Canete, Peter F. Ambros, Keith Holmes, Mark Gaze, Günter Schreier, Alberto Garaventa, Gilles Vassal, Jean Michon, Dominique Valteau-Couanet.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Lancet. Oncology
2017 : Vol. 18, nr 4, s. 500-514, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Ruth Ladenstein.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 36.418
Adres url:
Streszczenie w PubMed:
2/2
Maja Beck-Popovic, Emma Garcia, Nicole Gross, Valerine Combaret, Peter Ambros, Klaus Beiske, Alessandro Jenkner, Anne-Sophie Defachelles, Adela Canete, Benedicte Brichard, Walentyna Balwierz, Vassilios Papadakis, Shifra Ash, Ellen Ruud, Ruth Ladenstein, Ingrid Ora, Keith Holmes, Bruno De Bernardi, Jean Michon, Veronique Mosseri.
Characteristics of relapsing localized neuroblastoma : A prelimnary report of the second SIOPEN study (LNESG2, localized neuroblastoma European study group 2).
W: Advances in Neuroblastoma Research ANR 2010, Stockholm, Sweden, 21-24 June : programme and abstract book
s. 124 : abstr. OR60.
SZZ
AWZ
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ